Lilly, 3rd-Party Payor Class Argue Zyprexa Appeal

By Hilary Russ

Law360, New York (December 08, 2009, 6:23 PM ET) -- An appellate attorney for Eli Lilly & Co. has tried convincing a panel of justices to reverse the class certification granted to a group of insurers, labor unions and pension funds that says it overpaid for the antipsychotic Zyprexa given that the company didn't reveal the drug's adverse side effects.

Allowing the decision to stand in favor of the third-party payors would be “essentially a revolution” in the realm of class action litigation, Robert A. Long of Covington & Burling LLP, co-counsel for Lilly, told the...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

Already a subscriber?

  2. Forgot your password?
  4. Sign In

Get instant access to the one-stop news source for business lawyers

You must correct or enter the following before you can submit this form:

Required

Register